Keel Point Advisors’s Amgen AMGN Stock Holding History

Keel Point Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$517K	Buy	+3,246	New	+$506K	0.42%	29

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Keel Point Advisors's AMGN Position: Q4 2014 in Review

Keel Point Advisors opened a new position in Amgen (AMGN) in Q4 2014: 3,246 shares worth $517K. The stake represents 0.42% of the portfolio and ranks #29 among its holdings.

1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

Keel Point Advisors held 3,246 shares of Amgen worth $517K as of Q4 2014.
Amgen was a new Keel Point Advisors position in Q4 2014.
Amgen made up 0.42% of Keel Point Advisors's portfolio in Q4 2014, its #29 holding.
1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Keel Point Advisors's 13F filing for Q4 2014, filed 6 Feb 2015.